Escalation Strategies in the Treatment of Refractory Myasthenia Gravis

Neurology International Open
doi 10.1055/s-0043-125342
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Georg Thieme Verlag KG

Related search

Treatment for Refractory Myasthenia Gravis.

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
1989English

Understanding the Burden of Refractory Myasthenia Gravis

Therapeutic Advances in Neurological Disorders
NeurologyPharmacology
2019English

Long-Term Treatment of Refractory Myasthenia Gravis With Subcutaneous Immunoglobulin

Therapeutic Advances in Neurological Disorders
NeurologyPharmacology
2017English

Employment in Refractory Myasthenia Gravis: An Mgfa Registry Analysis

Muscle and Nerve
Molecular NeuroscienceNeurologyPhysiologyCellular
2019English

Rebooting the Immune System With High-Dose Cyclophosphamide for Treatment of Refractory Myasthenia Gravis

Annals of the New York Academy of Sciences
GeneticsMolecular BiologyBiochemistryNeuroscienceHistoryPhilosophy of Science
2008English

Refractory Myasthenia Gravis: Clinical Description and Literature Review

Scholars Journal of Applied Medical Sciences
2020English

Role of Rituximab in Myasthenia Gravis’ Treatment

Journal of Neurology & Stroke
2017English

Ephedrine Treatment for Autoimmune Myasthenia Gravis

Neuromuscular Disorders
Child HealthNeurologyPediatricsPerinatologyGenetics
2017English

Myasthenia Gravis

CMAJ
Medicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy